Valuation: Neuland Laboratories Limited

Market Cap 239B 2.53B 2.21B 2.04B 1.91B 3.59B 3.65B 24.5B 9.51B 118B 9.5B 9.29B 411B P/E 2026
42.3x
P/E 2027 * 57x
Enterprise Value 239B 2.53B 2.21B 2.04B 1.9B 3.59B 3.65B 24.49B 9.51B 118B 9.49B 9.28B 411B EV / Sales 2026
7.59x
EV / Sales 2027 * 10.1x
Free-Float
62.24%
Yield 2026
0.28%
Yield 2027 * 0.08%
1 day+0.81%
1 week+3.98%
Current month+0.81%
1 month+9.32%
3 months+48.99%
6 months+24.22%
Current year+23.64%
1 week 17,610
Extreme 17610
19,126
1 month 16,478.45
Extreme 16478.45
19,126
Current year 11,500
Extreme 11500
19,126
1 year 11,500
Extreme 11500
19,748.4
3 years 2,799.8
Extreme 2799.8
19,748.4
5 years 965.85
Extreme 965.85
19,748.4
10 years 247.3
Extreme 247.3
19,748.4
Manager TitleAgeSince
Chief Executive Officer 46 01/04/2026
Director of Finance/CFO - 23/11/2022
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 50 01/01/2002
Chairman 82 07/01/1984
Director/Board Member 46 01/03/2007
Change 5-day change 1-year change 3-year change Capi.($)
+0.87%+3.98%+58.16%+561.04% 2.53B
-2.48%+8.34%+53.87%+155.75% 1,070B
-1.76%+6.23%+66.27%+53.44% 611B
-1.05%+7.19%+35.57%+86.77% 445B
-1.34%+4.18%+31.11%+23.88% 329B
+0.40%+1.94%+36.32%+36.69% 290B
-0.14%+1.79%+29.27%+42.94% 287B
+1.51%+2.73%-26.99%-40.87% 213B
+0.44%+4.35%+29.69%+63.10% 195B
+0.01%+1.03%+13.95%+63.93% 157B
Average -0.33%+4.84%+32.72%+104.67% 359.88B
Weighted average by Cap. -1.10%+6.67%+40.43%+78.84%

Financials

2026 2027 *
Net sales 17.64B 187M 163M 151M 141M 265M 270M 1.81B 702M 8.7B 701M 685M 30.32B 23.33B 247M 216M 199M 186M 350M 357M 2.39B 928M 11.51B 927M 906M 40.11B
Net income 2.57B 27.21M 23.82M 21.98M 20.51M 38.64M 39.33M 264M 102M 1.27B 102M 99.94M 4.42B 4.21B 44.52M 38.97M 35.97M 33.55M 63.22M 64.35M 431M 168M 2.08B 167M 164M 7.24B
Net Debt -117M -1.23M -1.08M -996K -929K -1.75M -1.78M -11.94M -4.64M -57.49M -4.63M -4.53M -200M -3.18B -33.68M -29.48M -27.21M -25.39M -47.83M -48.69M -326M -127M -1.57B -127M -124M -5.47B
Logo Neuland Laboratories Limited
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Employees
1,794
Date Price Change Volume
01/07/26 18,791.80 +0.87% 3,650
30/06/26 ₹18,630.20 +3.14% 1,350
29/06/26 ₹18,062.80 +0.70% 982
25/06/26 ₹17,937.60 -0.69% 792
24/06/26 ₹18,062.40 -0.11% 4,773
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
18,630.20INR
Average target price
20,972.00INR
Spread / Average Target
+12.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NEULANDLAB Stock